(firstQuint)Study of FK463 for the Treatment of Invasive Aspergillosis.

 This will be an open-label, non-comparative study of intravenous FK463.

 Enrollment will include at least 100 patients evaluable for efficacy.

.

 Study of FK463 for the Treatment of Invasive Aspergillosis@highlight

The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with proven or probable invasive infections due to Aspergillus species.

